Crossmark

Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up

Crossref DOI link: https://doi.org/10.1186/s13058-017-0911-9

Published Online: 2017-11-14

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ohnstad, Hege O.

Borgen, Elin

Falk, Ragnhild S.

Lien, Tonje G.

Aaserud, Marit

Sveli, My Anh T.

Kyte, Jon A.

Kristensen, Vessela N.

Geitvik, Gry A.

Schlichting, Ellen

Wist, Erik A.

Sørlie, Therese

Russnes, Hege G.

Naume, Bjørn
Funding

Funding for this research was provided by:

South Eastern Health Authority, Norway

Kreftforeningen (NO)